Table 8.
Proportion of people on medication, mean QALYs and mean LDL-C at different thresholds – deterministic results
| Threshold LDL-C (mmol/L) | Mean QALYs | % of people on ezetimibe at 1 year | % of people on inclisiran at 1 year | Mean LDL-C at 1 year (mmol/L) |
|---|---|---|---|---|
| 4.0 | 5.959 | 1.5% | 0.7% | 1.91 |
| 3.1 | 5.973 | 5.9% | 1.5% | 1.87 |
| 2.7 | 5.994 | 13.2% | 4.2% | 1.79 |
| 2.4 | 6.021 | 22.4% | 7.8% | 1.70 |
| 2.2 | 6.046 | 31.2% | 13.2% | 1.60 |
| 2.0 | 6.078 | 42.3% | 18.8% | 1.50 |
| 1.8 | 6.115 | 50.6% | 31.2% | 1.35 |
| 1.5 | 6.174 | 73.9% | 50.6% | 1.12 |
| 1.2 | 6.225 | 88.7% | 74.6% | 0.92 |
| 0.8 | 6.253 | 99.6% | 94.8% | 0.79 |
Note: costs are not reported due to the confidentiality agreement on the price of inclisiran